Triple-Leveraged Biotech ETF Doubles as Regulatory Winds Shift in 2026

Core Viewpoint - Triple-leveraged ETFs, specifically the Direxion Daily S&P Biotech Bull 3X Shares (NASDAQ:LABU), are positioned as a high-risk, high-reward investment for those who believe in a significant upward movement in the biotech sector [1] Group 1: Investment Strategy - The Direxion Daily S&P Biotech Bull 3X Shares (LABU) provides an aggressive investment vehicle aimed at capitalizing on potential biotech sector growth [1]